about
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysisCalcium intake and bone mineral density: systematic review and meta-analysisCalcium intake and risk of fracture: systematic reviewResults of observational studies: analysis of findings from the Nurses' Health StudyClinical Trial Evidence and Use of Fish Oil SupplementsA comparison of adverse event and fracture efficacy data for strontium ranelate in regulatory documents and the publication recordConflicts of interest and expertise of independent commenters in news stories about medical researchDeterminants of vitamin D status in older women living in a subtropical climate.Determinants of vitamin D status in older men living in a subtropical climate.Press releases issued by supplements industry organisations and non-industry organisations in response to publication of clinical research findings: a case-control study.Vitamin D insufficiency and health outcomes over 5 y in older women.Calcium supplements and cardiovascular risk: 5 years onEffects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis.The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis.Vitamin D supplementation and falls: a trial sequential meta-analysis.Cardiovascular complications of calcium supplements.Calcium supplements: benefits and risks.Fracture-risk calculators: Has their time come?Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial.Media Coverage, Journal Press Releases and Editorials Associated with Randomized and Observational Studies in High-Impact Medical Journals: A Cohort StudyConcordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset.Differences between self-reported and verified adverse cardiovascular events in a randomised clinical trialCalcium supplementation and vascular disease.Randomised controlled trial of vitamin D supplementation in sarcoidosis.Role of ultrasound in the assessment of nodular thyroid disease.Does calcium supplementation increase cardiovascular risk?Calcium supplementation: balancing the cardiovascular risks.Calcium supplements and cancer risk: a meta-analysis of randomised controlled trials.Paget's disease of bone: clinical review and update.Skeletal health in adults with HIV infection.Republished: Paget's disease of bone: clinical review and update.Skeletal and nonskeletal effects of vitamin D: is vitamin D a tonic for bone and other tissues?Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis.Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men.The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trial.The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis.Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis?Circulating calcium concentrations, vascular disease and mortality: a systematic review.Management recommendations for osteoporosis in clinical guidelines.The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial.
P50
Q24548778-DB054C9D-D8A2-436E-B3EF-E91DCD0946CFQ26784337-E6CEBF5E-CBC6-4E5B-814B-2B8061B99372Q26784357-07856118-576C-47A6-831E-9AE81A460C6AQ27006022-A44E52E8-8E09-422B-AE0A-28FE3F9D0B66Q29396699-2173C34B-692F-4CDB-BEE5-3235EDEB5D82Q30857985-5E0B3857-CFB3-4F75-B3EC-869D4652A994Q33566189-6DEB9B4E-8281-4EAD-871B-50786D77D53EQ33844780-A262FEE2-5073-4D69-BCFB-24C408F34EBCQ33845051-7AD2ACCF-CD90-4E7B-BAE8-282A84A90DF4Q33845330-EE526C0E-AC50-4163-A6D1-EB237C49D262Q33846036-413B81E3-7158-40EE-ACF2-145B73526712Q34016231-6DED6F5C-F8E1-4966-9AD1-73DBD47EAB6DQ34377336-D9189C7B-6F87-40CA-9115-E42C9DBCAC39Q34413712-EC93C251-155E-42E0-BB4B-08F4DDFA6DC3Q34417236-6D91DFF1-789E-4DA0-B63B-1AD280DA5E26Q34452938-DF3DB1CB-3C4A-487F-9FE7-728562EA217EQ34485049-66988DCC-C0CE-4775-B1A9-2B2D1BB2DBA5Q34553117-932EDC46-4D76-43DA-90C8-590A53CA4989Q34587149-6B5CC06E-000D-4075-BB16-875076337A65Q35877928-84F3042E-7599-479D-81C0-5D7BF41BCD4AQ36126565-6675F071-7D07-4891-9526-F554C1F61197Q36730009-E2E7A972-181A-4393-99A0-4B682EBC95AEQ37223483-EFFA0F1B-248D-4E5A-A7FD-F19382A3DC97Q37256476-F4AFD0E6-3BB8-4257-B17C-7E0846B94FBDQ37519876-8257E63A-2AFB-4F06-9CE0-0B7C7EBF99AEQ37698674-36A8EB92-E31C-4549-B3F7-B4E80A1EB2C3Q37881381-2E9269BA-15F7-4193-84B0-860B5963B243Q38100376-15EFE196-5EFF-4125-919C-677139E5E4E4Q38138531-A1242F55-A2DA-4EEA-98CC-FB2B6A8F39DFQ38204540-585651DB-C95D-4A22-A5C6-C584F9C7512FQ38212331-9DB976B7-56A6-47DE-98F3-4B48BDFDDC79Q38213291-FAB8DF59-4F3A-482A-AC40-6D268B82D7CCQ38233352-38386058-2EF7-47ED-BCFB-57CF52393A17Q38385765-2CDC322F-A335-4ED9-A875-3DF90837AC70Q38441541-3FAA649D-6EC9-4DEE-9658-68EC058E6EB8Q38537377-B414A9BA-1381-46E8-8186-1D0B51389B8CQ38609024-18EEC995-C6CE-4701-8483-A4B165DF60ECQ38691493-7656B3FF-3794-4500-90DE-C4BA2572EECDQ40211419-46696EF6-4AF9-4F2A-8404-7E227BCAA27DQ40247162-60162BE8-AE46-4B56-B8F6-8050C8B5216F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mark J. Bolland
@ast
Mark J. Bolland
@en
Mark J. Bolland
@es
Mark J. Bolland
@sl
type
label
Mark J. Bolland
@ast
Mark J. Bolland
@en
Mark J. Bolland
@es
Mark J. Bolland
@sl
prefLabel
Mark J. Bolland
@ast
Mark J. Bolland
@en
Mark J. Bolland
@es
Mark J. Bolland
@sl
P1053
A-7554-2008
P106
P1153
8261810300
P21
P31
P3829
P496
0000-0003-0465-2674